Improving Learning How to Learn: Classrooms, Schools and Networks (2007)
James, M, McCormick, R, Black, P, Carmichael, P, Drummond, M, Fox, A, ...
Learning how to learn is an essential preparation for lifelong learning. Whilst this is widely acknowledged by teachers, they have lacked a rich professional knowledge base from which they can teach...
The effectiveness and cost-effectiveness of respite for caregivers of frail older people (2007)
Mason, A., Weatherly, H., Spilsbury, K., Golder, S., Arksey, H., Adamson, J., ...
The proportion of frail elderly people in the industrialized world is increasing. Respite care is a potentially important way of maintaining the quality of life for these people and their caregivers....
The effectiveness and cost-effectiveness of respite for caregivers of frail older people (2007)
Mason, A., Weatherly, H., Spilsbury, K., Golder, S., Arksey, H., Adamson, J., ...
The proportion of frail elderly people in the industrialized world is increasing. Respite care is a potentially important way of maintaining the quality of life for these people and their caregivers....
Learning How to Learn - in classrooms, schools and networks, TLRP Research Briefing 17 (2006)
James, M, McCormick, R, Marshall, B, Black, P, Carmichael, P, Drummond, M, ...
Research on assessment for learning has demonstrated that it can lead to improved learning and achievement. Less is known about how these results can be scaled up and sustained without intense...
How teachers engage with Assessment for Learning: lessons from the classroom (2006)
Using video recordings of lessons and interviews with teachers, this article explores the way in which teachers enact Assessment for Learning (AfL) practices in their classrooms. Starting with the...
Learning without limits (2005)
Hart, S, Dixon, A, Drummond, M, McIntyre, D
Curriculum Journal 16(1) abstracts D. James (2005) Importance and impotence? Learning, outcomes and research in Further ABSTRACT One of the defining features of the Teaching and Learning Research...
Hawkins, N., Epstein, D., Drummond, M., Wilby, J., Kainth, A., Chadwick, D., ...
Epilepsy currently affects more than 400,000 people in the United Kingdom and 2.3 million in the United States. Drug therapy is the mainstay of treatment for patients with epilepsy, but therapies...
Nixon, J., Duffy, S., Armstrong, N., Craig, D., Glanville, J., Christie, J., ...
OBJECTIVES: Health-care technology reviews now increasingly include outcome costs as well as clinical effects. This study reports the findings and implications of a survey to explore the usefulness...
Nixon, J., Duffy, S., Armstrong, N., Craig, D., Glanville, J., Christie, J., ...
OBJECTIVES: Health-care technology reviews now increasingly include outcome costs as well as clinical effects. This study reports the findings and implications of a survey to explore the usefulness...
Nixon, J., Duffy, S., Armstrong, N., Craig, D., Glanville, J., Christie, J., ...
OBJECTIVES: Health-care technology reviews now increasingly include outcome costs as well as clinical effects. This study reports the findings and implications of a survey to explore the usefulness...
Smith, D.H., Fenn, P., Drummond, M.
AIM: To estimate the potential cost effectiveness of photodynamic therapy (PDT) with verteporfin in the UK setting. METHODS: Using data from a variety of sources a Markov model was built to produce...
Smith, D.H., Fenn, P., Drummond, M.
AIM: To estimate the potential cost effectiveness of photodynamic therapy (PDT) with verteporfin in the UK setting. METHODS: Using data from a variety of sources a Markov model was built to produce...
Smith, D.H., Fenn, P., Drummond, M.
AIM: To estimate the potential cost effectiveness of photodynamic therapy (PDT) with verteporfin in the UK setting. METHODS: Using data from a variety of sources a Markov model was built to produce...
Issues for countries considering introducing the "fourth hurdle": The case of Hungary (2004)
Gulacsi, L., Boncz, I., Drummond, M.
Objectives: This study outlines the needs and current development of the “fourth hurdle” (i.e., requirement of effectiveness and cost-effectiveness data for drug coverage policy decisions) in...
Issues for countries considering introducing the "fourth hurdle": The case of Hungary (2004)
Gulacsi, L., Boncz, I., Drummond, M.
Objectives: This study outlines the needs and current development of the “fourth hurdle” (i.e., requirement of effectiveness and cost-effectiveness data for drug coverage policy decisions) in...
Issues for countries considering introducing the "fourth hurdle": The case of Hungary (2004)
Gulacsi, L., Boncz, I., Drummond, M.
Objectives: This study outlines the needs and current development of the “fourth hurdle” (i.e., requirement of effectiveness and cost-effectiveness data for drug coverage policy decisions) in...
Health care resouce use and stroke outcome (2003)
Asplund, K., Ashburner, S., Cargill, K., Hux, M., Lees, K., Drummond, M.
Background and Purpose: Outcome in patients hospitalized for acute stroke varies considerably between populations. Within the framework of the GAIN International trial, a large multicenter trial of a...
Health care resouce use and stroke outcome (2003)
Asplund, K., Ashburner, S., Cargill, K., Hux, M., Lees, K., Drummond, M.
Background and Purpose: Outcome in patients hospitalized for acute stroke varies considerably between populations. Within the framework of the GAIN International trial, a large multicenter trial of a...
Health care resouce use and stroke outcome (2003)
Asplund, K., Ashburner, S., Cargill, K., Hux, M., Lees, K., Drummond, M.
Background and Purpose: Outcome in patients hospitalized for acute stroke varies considerably between populations. Within the framework of the GAIN International trial, a large multicenter trial of a...
Assessing the appropriateness of combining economic data from multinational clinical trials (2003)
Cook, J.R., Drummond, M., Glick, H., Heyse, J.F.
Because of the potential for large variability among countries in the utilization and cost of health care resources, it is important to assess the appropriateness of combining economic data across...
Using Evidence in the development of local health policies (2002)
Weatherly, H., Drummond, M., Smith, D.
Objectives: This paper explores the use of evidence, focusing on economic evidence in particular, in the development of local health policies through an in-depth study of Health Improvement...
Using Evidence in the development of local health policies (2002)
Weatherly, H., Drummond, M., Smith, D.
Objectives: This paper explores the use of evidence, focusing on economic evidence in particular, in the development of local health policies through an in-depth study of Health Improvement...
Using Evidence in the development of local health policies (2002)
Weatherly, H., Drummond, M., Smith, D.
Objectives: This paper explores the use of evidence, focusing on economic evidence in particular, in the development of local health policies through an in-depth study of Health Improvement...
Best practice in undertaking and reporting health technology assessments (2002)
Busse, R., Orvain, J., Velasco, M., Perleth, M., Drummond, M., Gurtner, F., ...
[Executive Summary] The aim of Working Group 4 has been to develop and disseminate best practice in undertaking and reporting assessments, and to identify needs for methodologic development. Health...
Best practice in undertaking and reporting health technology assessments (2002)
Busse, R., Orvain, J., Velasco, M., Perleth, M., Drummond, M., Gurtner, F., ...
[Executive Summary] The aim of Working Group 4 has been to develop and disseminate best practice in undertaking and reporting assessments, and to identify needs for methodologic development. Health...
Best practice in undertaking and reporting health technology assessments (2002)
Busse, R., Orvain, J., Velasco, M., Perleth, M., Drummond, M., Gurtner, F., ...
[Executive Summary] The aim of Working Group 4 has been to develop and disseminate best practice in undertaking and reporting assessments, and to identify needs for methodologic development. Health...
When is it cost-effective to change the behavior of health professionals? (2001)
Mason, J., Freemantle, N., Nazareth, I., Eccles, M., Haines, A., Drummond, M.
Because of the workings of health care systems, new, important, and cost-effective treatments sometimes do not become routine care while well-marketed products of equivocal value achieve widespread...
When is it cost-effective to change the behaviour of health professionals ? (2001)
Mason, J. M., Freemantle, N., Nazareth, I., Eccles, M., Haines, A., Drummond, M.
Because of the workings of health care systems, new, important, and cost-effective treatments sometimes do not become routine care while well-marketed products of equivocal value achieve widespread...
When is it cost-effective to change the behavior of health professionals? (2001)
Mason, J., Freemantle, N., Nazareth, I., Eccles, M., Haines, A., Drummond, M.
Because of the workings of health care systems, new, important, and cost-effective treatments sometimes do not become routine care while well-marketed products of equivocal value achieve widespread...
Analyzing differences in the costs of treatment across centers within economic evaluations (2001)
Objectives: Assessments of health technologies increasingly include economic evaluations conducted alongside clinical trials. One particular concern with economic evaluations conducted alongside...
Analyzing differences in the costs of treatment across centers within economic evaluations (2001)
Objectives: Assessments of health technologies increasingly include economic evaluations conducted alongside clinical trials. One particular concern with economic evaluations conducted alongside...
Analyzing differences in the costs of treatment across centers within economic evaluations (2001)
Objectives: Assessments of health technologies increasingly include economic evaluations conducted alongside clinical trials. One particular concern with economic evaluations conducted alongside...
Shannon, C., Crombie, C., Brooks, A., Lau, H., Drummond, M., Gurney, H.
Purpose: To evaluate the activity and toxicity of gemcitabine and carboplatin in consecutive patients presenting with locally advanced or metastatic transitional cell carcinoma of the urothelium...
The UK NHS Economic Evaluation Database: Economic: Issues in evaluations of health technology (2000)
Nixon, J., Stoykova, B., Christie, J., Glanville, J.M., Drummond, M., Kleijnen, J.
OBJECTIVE: The U.K. NHS Economic Evaluation Database (EED) project is commissioned to identify papers on economic evaluations of health technologies and to disseminate their findings to NHS decision...
The UK NHS Economic Evaluation Database: Economic: Issues in evaluations of health technology (2000)
Nixon, J., Stoykova, B., Christie, J., Glanville, J.M., Drummond, M., Kleijnen, J.
OBJECTIVE: The U.K. NHS Economic Evaluation Database (EED) project is commissioned to identify papers on economic evaluations of health technologies and to disseminate their findings to NHS decision...
The UK NHS Economic Evaluation Database: Economic: Issues in evaluations of health technology (2000)
Nixon, J., Stoykova, B., Christie, J., Glanville, J.M., Drummond, M., Kleijnen, J.
OBJECTIVE: The U.K. NHS Economic Evaluation Database (EED) project is commissioned to identify papers on economic evaluations of health technologies and to disseminate their findings to NHS decision...
Report of the OMERACT Task Force on Economic Evaluation (1999)
Gabriel, S., Tugwell, P., OBrien, B., Yelin, E., Drummond, M., Ruff, B., ...
Report of the OMERACT Task Force on Economic Evaluation (1999)
Gabriel, S., Tugwell, P., OBrien, B., Yelin, E., Drummond, M., Ruff, B., ...
Acceptance for chronic dialysis treatment: insufficient and unequal (1996)
Sesso, R., Fernandes, P. Frassinetti, Anção, M., Drummond, M., Draibe, S., Sigulem, D., ...
Background. Evidence suggests that a number of end-stage renal disease (ESRD) patients die without receiving dialysis. We investigated and compared ESRD patients who died without receiving treatment...
Total-Order and Partial-Order Planning: A Comparative Analysis (1994)
Minton, S., Bresina, J., Drummond, M.
For many years, the intuitions underlying partial-order planning were largely taken for granted. Only in the past few years has there been renewed interest in the fundamental principles underlying...
Control of Herbaspirillum seropedicae NifA Activity by Ammonium Ions and Oxygen
Souza, E. M., Pedrosa, F. O., Drummond, M., Rigo, L. U., Yates, M. G.
The activity of a truncated form of Herbaspirillum seropedicae NifA in different genetic backgrounds showed that its regulatory domain is involved in nitrogen control but not in O2 sensitivity or Fe...
DNAPROBE, a computer program which generates oligonucleotide probes from protein alignments.
We describe a program to assist in designing oligonucleotide probes on the basis of protein alignments and the codon usage of the target organism. If necessary, the input sequences can be weighted to...
Drummond, M, Walmsley, J, Kennedy, C
In Azotobacter vinelandii, nifB is required for the activity of all three nitrogenases. Expression of a nifB-lacZ fusion was examined to determine which regulatory gene products are important for...
Frise, E, Green, A, Drummond, M
In vivo recombinants generating chimeras between the transcriptional activators VnfA and AnfA of Azotobacter vinelandii were constructed by cloning their structural genes in tandem and selecting...
Contreras, A, Drummond, M, Bali, A, Blanco, G, Garcia, E, Bush, G, ...
We sequenced the nitrogen fixation regulatory gene nfrX from Azotobacter vinelandii, mutations in which cause a Nif- phenotype, and found that it encodes a 105-kDa protein (NfrX), the N terminus of...
The DNA hybridization procedure of Southern has been used to search for homology between the transposable kanamycin resistance determinant Tn5 and sequences in the chromosome of Escherichia coli...
We have constructed mutations in what we predict to be the DNA-recognition helix of Klebsiella pneumoniae NtrC, which regulates transcription from promoters under global nitrogen control. Mutations...
Drummond, M, Whitty, P, Wootton, J
We have determined the nucleotide sequences of two genes from Klebsiella pneumoniae, nifA, the nif-specific activator of transcription and ntrC, the bifunctional regulatory protein involved in...
A framework for clinical evaluation of diagnostic technologies.
Guyatt, G H, Tugwell, P X, Feeny, D H, Haynes, R B, Drummond, M
Most new diagnostic technologies have not been adequately assessed to determine whether their application improves health. Comprehensive evaluation of diagnostic technologies includes establishing...
Some guidelines on the use of cost effectiveness league tables.
Mason, J, Drummond, M, Torrance, G
Decisions to allocate resources in health care are increasingly influenced by relative cost effectiveness. To warn decision makers of some of the pitfalls currently found in cost effectiveness league...
Control of Herbaspirillum seropedicae NifA Activity by Ammonium Ions and Oxygen
Souza, E. M., Pedrosa, F. O., Drummond, M., Rigo, L. U., Yates, M. G.
The activity of a truncated form of Herbaspirillum seropedicae NifA in different genetic backgrounds showed that its regulatory domain is involved in nitrogen control but not in O2 sensitivity or Fe...
DNAPROBE, a computer program which generates oligonucleotide probes from protein alignments.
We describe a program to assist in designing oligonucleotide probes on the basis of protein alignments and the codon usage of the target organism. If necessary, the input sequences can be weighted to...
Drummond, M, Walmsley, J, Kennedy, C
In Azotobacter vinelandii, nifB is required for the activity of all three nitrogenases. Expression of a nifB-lacZ fusion was examined to determine which regulatory gene products are important for...
Frise, E, Green, A, Drummond, M
In vivo recombinants generating chimeras between the transcriptional activators VnfA and AnfA of Azotobacter vinelandii were constructed by cloning their structural genes in tandem and selecting...
Contreras, A, Drummond, M, Bali, A, Blanco, G, Garcia, E, Bush, G, ...
We sequenced the nitrogen fixation regulatory gene nfrX from Azotobacter vinelandii, mutations in which cause a Nif- phenotype, and found that it encodes a 105-kDa protein (NfrX), the N terminus of...
The DNA hybridization procedure of Southern has been used to search for homology between the transposable kanamycin resistance determinant Tn5 and sequences in the chromosome of Escherichia coli...
We have constructed mutations in what we predict to be the DNA-recognition helix of Klebsiella pneumoniae NtrC, which regulates transcription from promoters under global nitrogen control. Mutations...
Drummond, M, Whitty, P, Wootton, J
We have determined the nucleotide sequences of two genes from Klebsiella pneumoniae, nifA, the nif-specific activator of transcription and ntrC, the bifunctional regulatory protein involved in...
A framework for clinical evaluation of diagnostic technologies.
Guyatt, G H, Tugwell, P X, Feeny, D H, Haynes, R B, Drummond, M
Most new diagnostic technologies have not been adequately assessed to determine whether their application improves health. Comprehensive evaluation of diagnostic technologies includes establishing...
Some guidelines on the use of cost effectiveness league tables.
Mason, J, Drummond, M, Torrance, G
Decisions to allocate resources in health care are increasingly influenced by relative cost effectiveness. To warn decision makers of some of the pitfalls currently found in cost effectiveness league...
Smith, D H, Fenn, P, Drummond, M
Aim: To estimate the potential cost effectiveness of photodynamic therapy (PDT) with verteporfin in the UK setting.
Knill-Jones, R., Drummond, M., Kohli, H., Davies, L.
This study assesses the economic benefits of misoprostol in the prophylaxis of gastric ulcers larger than 0.3 cm in patients with osteoarthritis receiving non-steroidal anti-inflammatory drugs....
Alternative Definitions of Health Care Programme Benefits for Contingent Valuation Studies
G Currie, C Donaldson, B O'Brien, G Stoddart, G Torrance, M Drummond
Alternative Definitions of Health Care Programme Benefits for Contingent Valuation Studies
G Currie, C Donaldson, B O'Brien, G Stoddart, G Torrance, M Drummond
Kohli, M, Ferko, N, Martin, A, Franco, E L, Jenkins, D, Gallivan, S, ...
To predict the public health impact on cervical disease by introducing human papillomavirus (HPV) vaccination in the United Kingdom, we developed a mathematical model that can be used to reflect the...
Pharmacoeconomics: friend or foe?
The financial constraints faced by most health systems today make it necessary for manufacturers of new, expensive drugs to demonstrate value for money. This paper describes the different types of...